The QUSTom project has implemented a dedicated action plan to permanently embed its commitment to gender equality in the actions of the project committed with the goals of Gender Equality Strategy 2020-2025.
“Working together, we can make real progress by 2025 in achieving a Europe where women and men, girls and boys, in all their diversity, are equal – where they are free to pursue their chosen path in life and reach their full potential, where they have equal opportunities to thrive, and where they can equally participate in and lead our European society” Gender Equality Strategy 2020-2025, European Commission.
Gender Equality Committee
|Josep Casellas||BSC – CNS|
|María Paz Baghetti||BSC – CNS|
|Claudia Gras||Frontwave Imaging|
Advocating for raising awareness
of gender equality issues,
both internally and externally.
Developing and implementing
a gender diversity
and accountability for various
initiatives within the gender
Monitoring the progress
and impact of the gender
Roles of female participants of the QUSTom project
- Lead Engineer: 2
- Project Manager: 3
- Business developer: 1
- Innovation Manager: 3
- Regulator Manager: 1
- Researcher: 6
- Dissemination Manager: 2
Gender balance in QUSTom project
Presence of women and men at events
Quotations of women and men in press
Why is it a priority to strengthen the integration of the gender dimension in research and innovation?
Adds value to research in terms of excellence, creativity and business opportunities
Helps researchers and innovators question gender norms and stereotypes, and rethink standards and reference models
Leads to an in-depth understanding of diverse gender needs, behaviours and attitudes
Addresses the diverse needs of citizens of the European Union and thereby enhances the societal relevance of the knowledge, technologies and innovations produced
Contributes to the production of goods and services better suited to new markets
Source: European Commission, Directorate-General for Research and Innovation, Gendered innovations 2 : how inclusive analysis contributes to research and innovation : policy review, Publications Office, 2020, https://data.europa.eu/doi/10.2777/316197
In QUSTom: principles and good practices
Method: analysing gender
- Gender stereotypes can affect clinical care in several ways. First, researchers should pay attention to language and gender norms in diagnostic procedures.
- Second, gender relations between the healthcare provider and the patient can affect prescribing patterns and treatment outcomes. Age and race can also play a role.
(Chang & Yang, 2021)
Mission area: cancer – ‘Conquering cancer: mission possible’
- Mission Board, include representatives from groups with sex and gender-specific knowledge, such as the Gender in Oncology task force of the European Society for Medical Oncology (ESMO). To ensure equal access and benefits to all European patients and citizens, sex and gender must be considered in cancer studies, cancer data analysis and modelling of treatments.
(European Commission, 2020)
- Sex is an important biological variable. All data collection and reporting must be sex disaggregated to facilitate future meta analyses.
- Gender is an important cultural variable. All data collection and reporting must be gender-disaggregated to facilitate future meta-analyses.
- If big data and machine learning techniques will be employed for low-cost population risk prediction, sex/gender bias in the source data needs to be investigated and corrected for.
- Polygenic risk score development needs to be based on sex-disaggregated data and possibly lead towards gender-sensitive risk counselling.
- Cancer prevention strategies should be gender-sensitive. This applies to the screening location (e.g. workplace versus primary care physician), delivery of information and facilitation of healthy lifestyle choices.
(European Institute for Gender Equality, 2016)
- Gender-specific barriers to access to early diagnostic and minimally invasive treatment technologies need to be removed in all EU Member States.
XR technologies are increasingly used for diagnosing and managing patients. These technologies may improve women’s health, for example by aiding early diagnosis of breast cancer or managing the symptoms of menopause.
(European Commission, 2020)
- The proposed European Cancer Patient Digital Centre needs to be equally accessible to all citizens, transcending possible inequalities in digital literacy.
- Sex and gender-specific risk factors should be recorded.
- The future network of comprehensive cancer infrastructures needs to include expertise on sex/gender in oncology.
- Innovation and implementation of new technology in the field of cancer need to be gender-sensitive to guarantee equal access and benefit for all.
(European Commission, 2020)
Quality of life
- Quality-of-life (QoL) measurements of patients, survivors, family members and carers need to be gender-sensitive. Cancer may affect the QoL of women, men and other genders differently, which needs to be considered for optimal support. Pain
- The prevention of chronic pain related to cancer should integrate sex analysis into treatments and develop gender-sensitive approaches to pain management.
- Pharmacological pain management needs to be gender-sensitive and sex-specific to improve patients’ outcomes and QoL.
(Laghousi, Jafari, Nikbakht, Nasiri, Shamshirgaran, & Aminisani, 2019)
- Personalised medicine approaches for cancer need to be sex-specific and gender sensitive to ensure equal access and benefits for all patients
Chia-Heng Chang & Fan Yang | (2021) How Gender Stereotypes Impact Health Information Seeking Intention: Insights from an Implicit Association Test, Cogent Social Sciences, 7:1, 1999614, DOI: 10.1080/23311886.2021.1999614
European Commission, Directorate-General for Research and Innovation, Pita Barros, P., Beets-Tan, R., Chomienne, C., et al., Conquering cancer : mission possible, Publications Office, 2020, https://data.europa.eu/doi/10.2777/045403
Lee S. K. (2018). Sex as an important biological variable in biomedical research. BMB reports, 51(4), 167–173. https://doi.org/10.5483/bmbrep.2018.51.4.034
EIGE. (2017). Gender in Health. DOI: 978-92-9493-614-1
Laghousi, D., Jafari, E., Nikbakht, H., Nasiri, B., Shamshirgaran, M., & Aminisani, N. (2019). Gender differences in health-related quality of life among patients with colorectal cancer. Journal of gastrointestinal oncology, 10(3), 453–461. https://doi.org/10.21037/jgo.2019.02.04
European Commission, Directorate-General for Research and Innovation, Gendered innovations 2 : how inclusive analysis contributes to research and innovation : policy review, Publications Office, 2020, https://data.europa.eu/doi/10.2777/316197
Send us your suggestions